To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene BRCA1P1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
306 supporting clones for gene BRCA1P1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AL701927 human skeletal muscle .a 1 to 460 1 to 460   tiling clone,   460/460
(100 %)
1 diff
(99.8 %id)
NM_007300.3   .a 1 to 7269 1 to 7269 exact RefSeq, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 7269/7269
(100 %)
0 diff
(100 %id)
DA904279   .a 87 to 643 2 to 558   capped   557/558
(99 %)
2 diff
(99.7 %id)
BC115037 PCR rescued clones .a 108 to 5936 13 to 5841 Q526* tiling clone,   5829/5854
(99 %)
19 diff
(99.7 %id)
BC012577 Bladder, carcinoma .a 110 to 2204 1 to 2095   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 2095/2101
(99 %)
10 diff
(99.6 %id)
BG777447 adenocarcinoma, Prostate .a 113 to 857 1 to 747   available from MGC,   747/747
(100 %)
9 diff
(98.8 %id)
BC030969 Prostate, adenocarcinoma. .a 114 to 2204 1 to 2088   tiling clone, available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 2088/2090
(99 %)
10 diff
(99.6 %id)
CN407395 embryonic stem cells, cell lines H1, H7, andH9 .a 119 to 794 1 to 674       674/674
(100 %)
3 diff
(99.6 %id)
AA205474   .a 131 to 533 1 to 411       409/418
(97 %)
8 diff
(98.1 %id)
BF028959 bladder, carcinoma, cell line .a 131 to 680 1 to 566   available from MGC,   566/1023
(55 %)
30 diff
(97.1 %id)
BC106745 PCR rescued clones .a 184 to 1651 1 to 1468       1468/1468
(100 %)
0 diff
(100 %id)
EL736761 mixed .a 233 to 819 1 to 587       587/587
(100 %)
0 diff
(100 %id)
DN998348 bone marrow .a 785 to 1443 8 to 666       659/666
(98 %)
7 diff
(99.0 %id)
BC062429 Bladder, carcinoma .a 882 to 2174 4 to 1293   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1290/1319
(97 %)
3 diff
(99.8 %id)
BE564528 bladder, carcinoma, cell line .a 902 to 1469 1 to 573   available from MGC,   573/575
(99 %)
18 diff
(96.9 %id)
CB158976 Liver .a 957 to 1484 1 to 528       528/528
(100 %)
0 diff
(100 %id)
BF508987   .a 1455 to 2193 737 to 4   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 734/739
(99 %)
0 diff
(100 %id)
AI589028 colon, moderately-differentiated adenocarcinoma .a 1553 to 2181 627 to 1       627/627
(100 %)
10 diff
(98.5 %id)
AI992040 anaplastic oligodendroglioma, brain .a 1553 to 2181 630 to 1       630/630
(100 %)
8 diff
(98.8 %id)
AA702344 liver and spleen .a 1640 to 2161 523 to 1       523/523
(100 %)
13 diff
(97.6 %id)
AA804632 germinal center B cell .a 1669 to 2180 518 to 9       510/518
(98 %)
0 diff
(100 %id)
AA814998 germinal center B cell .a 1700 to 2184 488 to 7       482/488
(98 %)
0 diff
(100 %id)
AA812019 germinal center B cell .a 1703 to 2184 487 to 7       481/487
(98 %)
0 diff
(100 %id)
AI040685 liver and spleen .a 1722 to 2180 459 to 1       459/459
(100 %)
24 diff
(94.8 %id)
AI016870 pooled .a 1771 to 2179 409 to 1       409/466
(87 %)
39 diff
(91.7 %id)
BQ308670 breast .a 1819 to 2260 1 to 443       443/443
(100 %)
9 diff
(98.0 %id)
BE043993 lymph node, lymphoma, follicular mixed small and largecell .a 1820 to 2420 602 to 1       602/602
(100 %)
11 diff
(98.2 %id)
DN912596   .a 1833 to 1972 140 to 1       140/140
(100 %)
1 diff
(99.3 %id)
BX956771   .a 1893 to 2486 1 to 594       594/594
(100 %)
1 diff
(99.9 %id)
BM452288 melanotic melanoma, skin .a 2038 to 3007 13 to 988   tiling clone,   976/1089
(89 %)
33 diff
(97.0 %id)
U25782 normal breast, pooled .a 2083 to 2295 1 to 212       212/212
(100 %)
3 diff
(98.6 %id)
AF274503   .a 2129 to 2779 1 to 649       649/649
(100 %)
1 diff
(99.9 %id)
DA807593 brain .a 2280 to 2825 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA784766 brain .a 2415 to 2999 2 to 586   tiling clone, capped   585/585
(100 %)
1 diff
(99.9 %id)
AA484941 germinal center B cell .a 2420 to 2848 1 to 429       429/429
(100 %)
4 diff
(99.1 %id)
AW968720   .a 2426 to 2945 525 to 6     Submitted on the opposite strand 520/666
(78 %)
0 diff
(100 %id)
AW295197   .a 2426 to 2974 554 to 7       548/563
(97 %)
0 diff
(100 %id)
AW968546   .a 2427 to 2974 1 to 547       547/585
(93 %)
10 diff
(98.3 %id)
CF144118 lymph .a 2467 to 2847 8 to 388       381/388
(98 %)
10 diff
(97.5 %id)
CF121736 lymph .a 2467 to 3199 8 to 739       732/739
(99 %)
6 diff
(99.2 %id)
TI_154175965   .a 2467 to 2866 77 to 476       400/401
(99 %)
4 diff
(99.1 %id)
TI_154181001   .a 2467 to 3265 69 to 865       797/797
(100 %)
10 diff
(98.8 %id)
CV353917 stomach .a 2494 to 2943 452 to 1     Submitted on the opposite strand 452/452
(100 %)
35 diff
(92.3 %id)
AI684595 pooled .a 2499 to 2951 453 to 1       453/453
(100 %)
1 diff
(99.8 %id)
AW292617   .a 2746 to 2974 234 to 7       228/234
(97 %)
0 diff
(100 %id)
BG178466 adenocarcinoma, cell line, Prostate .a 2855 to 3509 11 to 663       653/921
(70 %)
10 diff
(99.0 %id)
AA486004   .a 3110 to 3553 1 to 444       444/444
(100 %)
0 diff
(100 %id)
DA402848 thalamus .a 3157 to 3738 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
CK000353 mixed .a 3294 to 4084 1 to 788   tiling clone,   788/789
(99 %)
7 diff
(99.2 %id)
AL043576.
matches multiple genes
testis .a 3392 to 3651 1 to 260     also hits gene TRIP12 260/260
(100 %)
0 diff
(100 %id)
BF791668 adrenal cortex carcinoma, cell line, adrenal gland .a 3588 to 4330 1 to 736       736/900
(81 %)
15 diff
(98.4 %id)
DB251811 uterus .a 3599 to 4145 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
U68041 placenta .a 5186 to 6720 1 to 1536   tiling clone,   1536/1536
(100 %)
10 diff
(99.4 %id)
BQ878445 melanotic melanoma, cell line, skin .a 5291 to 6077 1 to 792   AAA   792/900
(88 %)
12 diff
(98.7 %id)
BM042282 melanotic melanoma, cell line, skin .a 5293 to 5906 1 to 619   fully sequenced,   619/619
(100 %)
15 diff
(97.6 %id)
BQ679749 melanotic melanoma, cell line, skin .a 5294 to 6214 25 to 947       923/947
(97 %)
19 diff
(98.0 %id)
BU163307 melanotic melanoma, cell line, skin .a 5294 to 6203 24 to 932       909/941
(96 %)
28 diff
(97.1 %id)
BU194336 melanotic melanoma, cell line, skin .a 5295 to 6202 1 to 916       916/922
(99 %)
15 diff
(98.4 %id)
BQ677666 melanotic melanoma, cell line, skin .a 5295 to 6018 1 to 723       723/910
(79 %)
20 diff
(97.9 %id)
BQ683955 melanotic melanoma, cell line, skin .a 5295 to 6201 1 to 916       916/933
(98 %)
25 diff
(97.4 %id)
BQ676829 melanotic melanoma, cell line, skin .a 5295 to 6068 1 to 776       776/909
(85 %)
15 diff
(98.4 %id)
BU155689 melanotic melanoma, cell line, skin .a 5307 to 6185 47 to 934       888/949
(93 %)
19 diff
(98.0 %id)
CB118225 Liver .a 5321 to 5865 1 to 545       545/546
(99 %)
3 diff
(99.5 %id)
BU552955 ovary, teratocarcinoma, cell line .a 5388 to 6280 1 to 894       894/894
(100 %)
13 diff
(98.6 %id)
BG530796 embryonal carcinoma, testis .a 5532 to 6217 1 to 696       696/841
(82 %)
29 diff
(96.6 %id)
CF143993 lymph .a 5555 to 5944 4 to 393       390/394
(98 %)
8 diff
(98.0 %id)
TI_154175799   .a 5559 to 5964 78 to 483       406/407
(99 %)
3 diff
(99.3 %id)
CB108172 Liver .a 5594 to 5994 1 to 401       401/401
(100 %)
0 diff
(100 %id)
BQ681242 melanotic melanoma, cell line, skin .a 5700 to 6462 1 to 769   tiling clone,   769/959
(80 %)
10 diff
(99.0 %id)
BU163141 melanotic melanoma, cell line, skin .a 5702 to 6468 30 to 805       776/980
(79 %)
20 diff
(98.0 %id)
BF768149 colon_normal .a 5872 to 6135 25 to 293       269/293
(91 %)
6 diff
(98.0 %id)
BM042892 melanotic melanoma, cell line, skin .a 5876 to 6678 826 to 16   fully sequenced,   811/826
(98 %)
32 diff
(96.2 %id)
CB150491 cervix, Uterine .a 5884 to 6364 1 to 478       478/478
(100 %)
11 diff
(97.7 %id)
Y08864 placenta .a 5885 to 7259 1 to 1375   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 1375/1375
(100 %)
4 diff
(99.8 %id)
BF983078 duodenal adenocarcinoma, cell line, small intestine .a 5992 to 6755 1 to 758       758/961
(78 %)
25 diff
(97.4 %id)
BE832652 ovary .a 6040 to 6342 23 to 325       303/325
(93 %)
6 diff
(98.2 %id)
CX754378 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 6085 to 6783 1 to 697   tiling clone, Submitted on the opposite strand 697/697
(100 %)
1 diff
(99.9 %id)
AA205436   .a 6105 to 6741 631 to 1       631/633
(99 %)
14 diff
(97.8 %id)
AA608570 lung, lung carcinoma .a 6143 to 6745 602 to 1       602/602
(100 %)
6 diff
(99.1 %id)
AL135363 melanoma (MeWo cell line) .a 6162 to 6741 1 to 580   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 580/580
(100 %)
1 diff
(99.9 %id)
TI_154134646   .a 6191 to 6741 661 to 101   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 561/1010
(55 %)
17 diff
(98.4 %id)
CK822698 Pancreas, Purified pancreatic islet .a 6209 to 6741 1 to 533   AAA Submitted on the opposite strand 533/533
(100 %)
1 diff
(99.9 %id)
TI_154173253   .a 6214 to 6761 641 to 91     Submitted on the opposite strand 551/1153
(47 %)
0 diff
(100 %id)
BM503804 Pancreas, Purified pancreatic islet .a 6228 to 6636 1 to 408       408/408
(100 %)
6 diff
(98.6 %id)
CK822699 Pancreas, Purified pancreatic islet .a 6243 to 6749 507 to 1     Submitted on the opposite strand 507/507
(100 %)
2 diff
(99.7 %id)
FN134050 breast carcinoma .a 6245 to 6342 1 to 100       100/100
(100 %)
2 diff
(98.0 %id)
AW514868 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 6276 to 6744 469 to 1       469/469
(100 %)
0 diff
(100 %id)
CF142324 lymph .a 6320 to 6741 452 to 31   AAA Submitted on the opposite strand 422/422
(100 %)
0 diff
(100 %id)
AI680547 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 6335 to 6743 409 to 1       409/409
(100 %)
1 diff
(99.8 %id)
BP388801 pancreatic islet .a 6339 to 6746 1 to 408     Submitted on the opposite strand 408/408
(100 %)
0 diff
(100 %id)
AA111870 muscle, skeletal muscle .a 6359 to 6746 1 to 389   fully sequenced,   389/389
(100 %)
1 diff
(99.8 %id)
CN407392 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 6390 to 6641 1 to 252       252/252
(100 %)
1 diff
(99.7 %id)
CN407390 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 6441 to 6741 13 to 313   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 301/313
(96 %)
6 diff
(98.1 %id)
AW575729 lymph .a 6441 to 6758 318 to 1       318/318
(100 %)
3 diff
(99.1 %id)
BX497486 Liver .a 6469 to 7075 1 to 604       604/604
(100 %)
20 diff
(96.7 %id)
BX102233 liver and spleen .a 6540 to 7259 1 to 717   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 717/717
(100 %)
4 diff
(99.5 %id)
H90469 liver and spleen .a 6540 to 6742 1 to 203       203/203
(100 %)
0 diff
(100 %id)
AA086435 muscle, skeletal muscle .a 6547 to 6696 149 to 1   fully sequenced,   149/149
(100 %)
0 diff
(100 %id)
BU617173 Bone, Subchondral Bone .a 6584 to 7268 702 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 684/684
(100 %)
1 diff
(99.9 %id)
AW964452   .a 6586 to 7139 1 to 553       553/555
(99 %)
14 diff
(97.5 %id)
TI_154134735   .a 6651 to 7263 711 to 93   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 619/1350
(45 %)
31 diff
(97.8 %id)
TI_154134733   .a 6666 to 7263 699 to 93   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 607/1217
(49 %)
20 diff
(98.4 %id)
TI_149276118   .a 6668 to 7265 165 to 761   AAA Submitted on the opposite strand 597/761
(78 %)
5 diff
(99.4 %id)
BU677011 lung, Primary Lung Epithelial Cells .a 6668 to 7233 55 to 620     Submitted on the opposite strand 566/620
(91 %)
6 diff
(99.1 %id)
AA917008 carcinoid, lung .a 6714 to 7037 7 to 329     Submitted on the opposite strand 323/329
(98 %)
6 diff
(98.2 %id)
BF447679 carcinoid, lung .a 6714 to 7202 11 to 500     Submitted on the opposite strand 490/500
(98 %)
6 diff
(98.8 %id)
BQ360833 ovary .a 6748 to 7025 278 to 2       277/303
(91 %)
0 diff
(100 %id)
TI_149280688   .a 6768 to 7269 580 to 79   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 502/698
(71 %)
4 diff
(99.5 %id)
BU679389 lung, Primary Lung Epithelial Cells .a 6768 to 7269 520 to 19   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 502/506
(99 %)
4 diff
(99.3 %id)
TI_154168560   .a 6770 to 7264 577 to 83     Submitted on the opposite strand 495/498
(99 %)
0 diff
(100 %id)
AA773331 lung, lung carcinoma .a 6810 to 7267 471 to 14   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 458/458
(100 %)
3 diff
(99.4 %id)
CF138586 lymph .a 6818 to 7269 457 to 6     Submitted on the opposite strand 452/457
(98 %)
0 diff
(100 %id)
H90415 liver and spleen .a 6856 to 7243 389 to 1       389/391
(99 %)
3 diff
(99.3 %id)
AW673569 cervix .a 6916 to 7264 1 to 349       349/349
(100 %)
3 diff
(99.2 %id)
AI217721 pooled .a 6960 to 7267 311 to 4       308/311
(99 %)
0 diff
(100 %id)
AA865794 Kidney .a 7002 to 7270 270 to 2   tiling clone,   269/270
(99 %)
0 diff
(100 %id)
U25774 normal breast, pooled .a 7133 to 7259 1 to 127       127/132
(96 %)
1 diff
(99.3 %id)
NM_007294.3   .b 1 to 7206 1 to 7206 exact RefSeq, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 7206/7206
(100 %)
0 diff
(100 %id)
U14680   .b 115 to 5824 1 to 5711 exact tiling clone,   5711/5711
(100 %)
5 diff
(100.0 %id)
AY751490   .b 233 to 5756 1 to 5524       5524/5524
(100 %)
7 diff
(99.9 %id)
AU125312   .b 4055 to 4754 2 to 702   capped   701/701
(100 %)
2 diff
(99.8 %id)
DB276389 uterus .b 4256 to 4799 2 to 545   capped   544/544
(100 %)
2 diff
(99.7 %id)
BF794879 lymph, lymphoma, cell line .b 4467 to 5218 1 to 746       746/800
(93 %)
39 diff
(95.2 %id)
FN125180 breast carcinoma .b 4533 to 4636 104 to 1     Submitted on the opposite strand 104/104
(100 %)
0 diff
(100 %id)
CR735417 brain, neuroblastoma, cell line .b 4557 to 5060 20 to 523       504/523
(96 %)
6 diff
(98.9 %id)
CB136844 Liver .b 4573 to 4976 1 to 404       404/404
(100 %)
0 diff
(100 %id)
AU148997   .b 6152 to 6678 526 to 1   tiling clone,   526/545
(96 %)
8 diff
(98.6 %id)
NM_007297.3   .c 1 to 7114 1 to 7114 exact RefSeq, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 7114/7114
(100 %)
0 diff
(100 %id)
DC360426   .c 50 to 613 1 to 564   tiling clone,   564/564
(100 %)
0 diff
(100 %id)
BC115036 PCR rescued clones .c 76 to 5781 5720 to 16 T749Q E750N P751Q N752I K753N ... tiling clone, Submitted on the opposite strand 5705/5732
(99 %)
4 diff
(100.0 %id)
BC115038 PCR rescued clones .c 76 to 5781 5720 to 16 T749Q E750N P751Q N752I K753N ...   Submitted on the opposite strand 5705/5732
(99 %)
4 diff
(100.0 %id)
NR_027676.1   .d 1 to 7109 2 to 7110 exact RefSeq, tiling clone, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 7110/7110
(100 %)
0 diff
(100 %id)
AF005068 testis .d 35 to 5727 1 to 5693 I19T G1006R     5693/5693
(100 %)
7 diff
(99.9 %id)
AY354539   .e 1 to 4497 1 to 4497 exact tiling clone,   4497/4497
(100 %)
9 diff
(99.8 %id)
NM_007298.3   .f 1 to 3681 1 to 3681 exact RefSeq, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 3681/3681
(100 %)
0 diff
(100 %id)
U64805 breast .f 20 to 2299 1 to 2280   tiling clone,   2280/2280
(100 %)
5 diff
(99.8 %id)
AK293762 cerebellum .g 1 to 2420 1 to 2420 exact tiling clone,   2420/2420
(100 %)
0 diff
(100 %id)
DC306913 cerebellum .g 1 to 561 1 to 561       561/561
(100 %)
0 diff
(100 %id)
DN912595   .g 149 to 228 12 to 91       79/91
(86 %)
6 diff
(93.5 %id)
BQ068830 brain, neuroblastoma, cell line .g 1105 to 2026 32 to 958       927/962
(96 %)
22 diff
(97.8 %id)
BM749007 stomach .g 1123 to 1342 5 to 224       220/224
(98 %)
12 diff
(94.7 %id)
BM755214 stomach .g 1164 to 1562 1 to 399       399/399
(100 %)
0 diff
(100 %id)
BM755305 stomach .g 1198 to 1498 1 to 301       301/301
(100 %)
0 diff
(100 %id)
DB244742 uterus, tumor tissue .g 1205 to 1771 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DN602021 human embryonic stem cells .g 1222 to 1733 1 to 512       512/512
(100 %)
0 diff
(100 %id)
CN407393 embryonic stem cells, cell lines H1, H7, andH9 .g 1232 to 1965 1 to 735       735/735
(100 %)
1 diff
(99.9 %id)
AW504244 lymph .g 1282 to 1783 8 to 509       502/509
(98 %)
7 diff
(98.7 %id)
TI_154160377   .g 1282 to 1830 85 to 633       549/550
(99 %)
1 diff
(99.9 %id)
EC493833 Prostate .g 1288 to 1385 1 to 97       97/98
(98 %)
3 diff
(97.0 %id)
BQ214737 embryonal carcinoma, cell line, testis .g 1333 to 1829 1 to 498       498/1220
(40 %)
7 diff
(99.5 %id)
BU171200 melanotic melanoma, skin .g 1346 to 2154 12 to 834       821/933
(87 %)
20 diff
(97.9 %id)
BG681276 skin, squamous cell carcinoma .g 1361 to 2102 1 to 742       742/743
(99 %)
2 diff
(99.8 %id)
DB041000 testis .g 1419 to 1971 2 to 555   capped   554/554
(100 %)
3 diff
(99.5 %id)
BE264293 lung, small cell carcinoma .g 1459 to 2091 1 to 638       638/638
(100 %)
20 diff
(96.9 %id)
BQ378695 uterus_tumor .g 1533 to 1884 56 to 408       353/424
(83 %)
10 diff
(97.7 %id)
BQ378479 uterus_tumor .g 1553 to 1884 1 to 331       331/349
(94 %)
11 diff
(96.9 %id)
BM988066 mixed .g 1569 to 1938 375 to 7   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 369/375
(98 %)
0 diff
(100 %id)
CB155501 Liver .g 1694 to 2324 1 to 631       631/631
(100 %)
0 diff
(100 %id)
DB038439 testis .g 1697 to 2260 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
CN407391 embryonic stem cells, DMSO-treated H9 cellline .g 1711 to 2163 1 to 456       456/457
(99 %)
4 diff
(99.2 %id)
BQ318059 colon .g 1771 to 2029 1 to 260       260/260
(100 %)
11 diff
(95.8 %id)
EH342654   .g 1812 to 1865 1 to 54       54/54
(100 %)
0 diff
(100 %id)
BG950333 colon .g 1871 to 2010 143 to 5       139/144
(96 %)
2 diff
(98.7 %id)
CN407394 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 1928 to 2111 1 to 184       184/184
(100 %)
0 diff
(100 %id)
BC072418 Peripheral Nervous System, dorsal rootganglion .h 1 to 3254 1 to 3254 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 3254/3254
(100 %)
1 diff
(100.0 %id)
NM_007299.3   .h 1 to 3782 1 to 3782 exact RefSeq, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 3782/3782
(100 %)
0 diff
(100 %id)
BU147444 dorsal root ganglia .h 2 to 851 1 to 855   available from MGC,   855/856
(99 %)
7 diff
(99.2 %id)
CF596982 ovary .h 78 to 600 1 to 526       526/886
(59 %)
9 diff
(99.0 %id)
AL704228 human skeletal muscle .h 82 to 756 1 to 675       675/675
(100 %)
1 diff
(99.9 %id)
AU098869   .h 129 to 427 1 to 300       300/300
(100 %)
3 diff
(99.0 %id)
TI_1948233072   .h 195 to 1191 131 to 1122       992/1378
(71 %)
27 diff
(98.1 %id)
TI_1948233228   .h 195 to 1246 128 to 1180       1053/1404
(75 %)
47 diff
(96.7 %id)
TI_1948233375   .h 195 to 1070 131 to 1006       876/1436
(61 %)
13 diff
(99.1 %id)
TI_1948233531   .h 195 to 1240 126 to 1164       1039/1350
(76 %)
37 diff
(97.3 %id)
TI_1948233532   .h 1402 to 2284 1030 to 135       896/1148
(78 %)
18 diff
(98.5 %id)
TI_1948233376   .h 1470 to 2284 954 to 132       823/1180
(69 %)
11 diff
(99.1 %id)
TI_1948233229   .h 1559 to 2284 861 to 135       727/1185
(61 %)
2 diff
(99.9 %id)
TI_1948233073   .h 1604 to 2284 819 to 131       689/1288
(53 %)
18 diff
(98.7 %id)
CX761410 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .h 1670 to 2452 1 to 774     Submitted on the opposite strand 774/828
(93 %)
14 diff
(98.4 %id)
AK308084   .i 1 to 2107 2 to 2106   tiling clone,   2106/2106
(100 %)
2 diff
(100.0 %id)
DA730134   .i 1 to 813 2 to 816   capped   815/815
(100 %)
4 diff
(99.6 %id)
AK307553   .j 1 to 1979 2 to 1980 exact tiling clone,   1980/1980
(100 %)
0 diff
(100 %id)
DA618294   .j 1 to 593 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
BC085615 Testis, embryonal carcinoma .k 1 to 1959 1 to 1959 exact tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1959/1959
(100 %)
0 diff
(100 %id)
BQ422380 embryonal carcinoma, cell line, testis .k 4 to 887 1 to 893       893/899
(99 %)
21 diff
(97.7 %id)
DA611389   .l 1 to 456 2 to 457   tiling clone, capped   456/456
(100 %)
0 diff
(100 %id)
BC038947 Uterus, leiomyosarcoma .l 354 to 1905 12 to 1563   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 1552/1552
(100 %)
0 diff
(100 %id)
BM800251 leiomyosarcoma, uterus .l 361 to 1286 1 to 938   available from MGC,   938/987
(95 %)
17 diff
(98.3 %id)
AK316200   .m 1 to 1943 6 to 1948 exact tiling clone,   1948/1948
(100 %)
0 diff
(100 %id)
BE018878 Kidney, renal cell adenocarcinoma .n 1 to 509 1 to 509   tiling clone,   509/509
(100 %)
3 diff
(99.5 %id)
BE206562 Kidney, renal cell adenocarcinoma .n 2071 to 2558 488 to 1   tiling clone,   488/488
(100 %)
1 diff
(99.8 %id)
BP326847 prostata .o 1 to 582 1 to 582   tiling clone,   582/582
(100 %)
1 diff
(99.9 %id)
DR006061 Prostate .o 19 to 532 1 to 514       514/515
(99 %)
4 diff
(99.3 %id)
BF795489 lymph, lymphoma, cell line .o 343 to 1014 1 to 671   available from MGC,   671/950
(70 %)
6 diff
(99.4 %id)
BC046142 Lymph, lymphoma .o 344 to 1828 1 to 1485   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 1485/1485
(100 %)
1 diff
(100.0 %id)
BC114562 PCR rescued clones .p 1 to 1462 1 to 1463 V354G D355R L356S N357E A358C ... tiling clone,   1463/1463
(100 %)
1 diff
(100.0 %id)
BC114511 PCR rescued clones .q 1 to 1584 1 to 1584 exact tiling clone,   1584/1584
(100 %)
1 diff
(100.0 %id)
AU142729   .r 1 to 778 2 to 780   tiling clone, capped   779/782
(99 %)
4 diff
(99.5 %id)
AU122476 mammary gland .r 241 to 1080 2 to 844   tiling clone, capped   843/844
(99 %)
7 diff
(99.2 %id)
DB384211   .r 1325 to 1809 483 to 1   tiling clone,   483/484
(99 %)
28 diff
(94.3 %id)
DB361888 mammary gland .r 1388 to 1948 553 to 1   tiling clone,   553/554
(99 %)
12 diff
(97.9 %id)
CF995798 mixed .r 1457 to 1948 22 to 512   tiling clone, AAA Possibly primed on the genome, locally A rich (18/18 A in genome downstream of last aligned base) 491/512
(95 %)
13 diff
(97.5 %id)
DQ363751   .s 1 to 1282 1 to 1282 S104G A321T tiling clone,   1282/1282
(100 %)
5 diff
(99.7 %id)
BC106746 PCR rescued clones .t 1 to 779 1 to 779 exact tiling clone,   779/779
(100 %)
0 diff
(100 %id)
BQ215100 melanotic melanoma, skin .u 1 to 770 1 to 773 V198G D200R Q201S E202R L203I ... tiling clone,   771/878
(87 %)
5 diff
(99.5 %id)
BG257190 embryonal carcinoma, cell line, testis .u 4 to 692 1 to 687       687/938
(73 %)
6 diff
(99.4 %id)
DA232101 brain .va-u 1 to 562 2 to 564   tiling clone, to resequence, capped   563/563
(100 %)
3 diff
(99.5 %id)
BX955053   .va-u 338 to 888 1 to 551 exact tiling clone,   551/551
(100 %)
1 diff
(99.9 %id)
BF793217 adrenal cortex carcinoma, cell line, adrenal gland .va-u 1582 to 2195 14 to 634   tiling clone,   621/753
(82 %)
26 diff
(96.6 %id)
CN275051 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .va-u 1749 to 2459 1 to 711   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 711/717
(99 %)
1 diff
(99.9 %id)
BE328571 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .va-u 1870 to 2350 481 to 1       481/481
(100 %)
0 diff
(100 %id)
BE328517 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .va-u 1949 to 2350 402 to 1       402/402
(100 %)
0 diff
(100 %id)
AI219788 pooled .va-u 1953 to 2349 397 to 1       397/397
(100 %)
5 diff
(98.8 %id)
AA884444 pooled .va-u 2025 to 2351 327 to 1       327/327
(100 %)
0 diff
(100 %id)
AA927794 pooled .va-u 2035 to 2457 424 to 1       424/424
(100 %)
3 diff
(99.3 %id)
DA778332 brain .va-u 2037 to 2615 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
AI560251 anaplastic oligodendroglioma, brain .va-u 2040 to 2451 416 to 1       416/416
(100 %)
5 diff
(98.8 %id)
AW874068 follicular carcinoma, thyroid .va-u 2040 to 2531 498 to 7       492/498
(98 %)
0 diff
(100 %id)
DR005045 placenta .va-u 2194 to 2821 7 to 633   tiling clone,   627/633
(99 %)
1 diff
(99.9 %id)
AK023326 ovary, tumor tissue .va-u 2357 to 4456 1 to 2099   tiling clone, available from FLJ,   2099/2099
(100 %)
4 diff
(99.9 %id)
AU133926 ovary, tumor tissue .va-u 2358 to 3011 2 to 654   capped   653/653
(100 %)
4 diff
(99.4 %id)
DA152961 amygdala .va-u 2998 to 3564 2 to 564   capped   563/563
(100 %)
4 diff
(99.3 %id)
AL833687 lymph node .va-u 3236 to 4456 1 to 1221   available from DKFZ, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 1221/1221
(100 %)
2 diff
(99.9 %id)
BI223868 cervical carcinoma cell line, cervix .va-u 3236 to 3966 13 to 746       734/746
(98 %)
11 diff
(98.6 %id)
BE071923 breast .va-u 3557 to 3822 266 to 1     Submitted on the opposite strand 266/266
(100 %)
0 diff
(100 %id)
BQ008883 Chondrosarcoma, Left Pelvis .va-u 3688 to 4456 778 to 19   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 760/776
(97 %)
10 diff
(98.8 %id)
AU155084 ovary, tumor tissue .va-u 3881 to 4456 575 to 1       575/587
(97 %)
21 diff
(96.5 %id)
BQ212209 embryonal carcinoma, cell line, testis .va-u 3922 to 4456 1 to 535   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 535/535
(100 %)
0 diff
(100 %id)
DB305521 brain .va-u 3978 to 4520 543 to 1   tiling clone, to resequence,   543/543
(100 %)
0 diff
(100 %id)
AI983600 colon, colonic mucosa from 3 patients with Crohn'sdisease .va-u 3994 to 4458 465 to 1       465/465
(100 %)
4 diff
(99.2 %id)
BX093256 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .va-u 4008 to 4456 1 to 449   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 449/449
(100 %)
0 diff
(100 %id)
AA421696 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .va-u 4091 to 4456 364 to 1       364/364
(100 %)
4 diff
(99.0 %id)
DQ333386   .vb 1 to 781 1 to 781 exact tiling clone,   781/781
(100 %)
0 diff
(100 %id)
DC405381 thymus .vc 1 to 577 1 to 577 R50T tiling clone,   577/577
(100 %)
1 diff
(99.9 %id)
DQ333387   .vd 1 to 563 1 to 563 S2D M16I D46G tiling clone,   563/563
(100 %)
4 diff
(99.3 %id)
AK311131 cerebellum .ve 1 to 1190 2 to 1191 R20T tiling clone,   1191/1191
(100 %)
1 diff
(100.0 %id)
DC310106 cerebellum .ve 1 to 536 2 to 537       537/537
(100 %)
0 diff
(100 %id)
DC353435 brain .ve 88 to 649 1 to 562       562/562
(100 %)
2 diff
(99.7 %id)
CN278627 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .ve 188 to 685 1 to 498       498/498
(100 %)
1 diff
(99.8 %id)
AW269595 pooled .ve 341 to 805 471 to 7       465/471
(98 %)
1 diff
(99.8 %id)
DA758399   .ve 1039 to 1564 2 to 527   tiling clone, capped   526/526
(100 %)
0 diff
(100 %id)
AK093551 thymus .ve 1205 to 3493 1 to 2287   tiling clone, available from FLJ,   2287/2287
(100 %)
4 diff
(99.9 %id)
DB102185 thymus .ve 1206 to 1760 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
AA972584 carcinoid, lung .ve 1349 to 1773 424 to 1       424/424
(100 %)
1 diff
(99.8 %id)
DB283325 uterus .ve 1430 to 1978 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
CN280476 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .ve 1456 to 2112 6 to 662       657/662
(99 %)
5 diff
(99.3 %id)
DB165086 thymus .ve 1778 to 2370 2 to 594   capped   593/593
(100 %)
1 diff
(99.9 %id)
H83488 eye, retina .ve 1802 to 2197 13 to 408       396/408
(97 %)
6 diff
(98.6 %id)
DB088647 testis .ve 1834 to 2385 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
CN280475 embryonic stem cells, DMSO-treated H9 cellline .ve 2031 to 2669 1 to 639       639/639
(100 %)
0 diff
(100 %id)
DB342518 thymus .ve 2903 to 3493 590 to 1   tiling clone,   590/590
(100 %)
4 diff
(99.4 %id)
H83489 eye, retina .ve 3131 to 3430 300 to 1   tiling clone,   300/300
(100 %)
1 diff
(99.7 %id)
DA092902 cerebellum .vf 1 to 558 2 to 559   tiling clone, capped   558/558
(100 %)
5 diff
(99.2 %id)
DA328702 hippocampus .vf 131 to 679 2 to 551   tiling clone, capped   550/550
(100 %)
7 diff
(98.8 %id)
AJ712908 bone marrow .vf 198 to 301 1 to 104       104/104
(100 %)
0 diff
(100 %id)
BF914928 uterus_tumor .vf 344 to 764 421 to 1   tiling clone, Submitted on the opposite strand 421/421
(100 %)
1 diff
(99.8 %id)
CD517309 White Matter .vf 381 to 1117 1 to 745   tiling clone,   745/894
(83 %)
32 diff
(96.5 %id)
BF914934 uterus_tumor .vf 420 to 764 345 to 1     Submitted on the opposite strand 345/345
(100 %)
2 diff
(99.5 %id)
BQ883435 brain, neuroblastoma, cell line .vf 830 to 1721 1 to 900   tiling clone,   900/900
(100 %)
19 diff
(97.9 %id)
BF921620 nervous_tumor .vf 1098 to 1449 346 to 1   tiling clone, Submitted on the opposite strand 346/348
(99 %)
7 diff
(98.0 %id)
BG546591 lung .vf 1667 to 2303 1 to 639 H47E T48R E51K E52R E53Q ... tiling clone,   639/746
(85 %)
21 diff
(97.2 %id)
AL603474 human skeletal muscle .vf 1996 to 2525 1 to 530   tiling clone,   530/530
(100 %)
9 diff
(98.4 %id)
AW771845 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .vf 2208 to 2605 430 to 31   tiling clone, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 400/400
(100 %)
3 diff
(99.3 %id)
BX481090   .vf 2382 to 2872 21 to 514       494/514
(96 %)
6 diff
(98.9 %id)
BX481077   .vf 2399 to 2872 1 to 476   tiling clone,   476/476
(100 %)
2 diff
(99.6 %id)
BM718493 eye, fetal eye .vg-u 1 to 388 1 to 388 K9E tiling clone, fully sequenced,   388/388
(100 %)
2 diff
(99.5 %id)
BM683538 eye, fetal eye .vg-u 358 to 903 546 to 1   tiling clone, fully sequenced,   546/546
(100 %)
3 diff
(99.5 %id)
AI660427 colon, colonic mucosa from 3 patients with Crohn'sdisease .vg-u 485 to 888 404 to 1   tiling clone,   404/404
(100 %)
1 diff
(99.8 %id)
CN264971 embryonic stem cells, cell lines H1, H7, andH9 .vh-u 1 to 733 1 to 733 exact tiling clone,   733/733
(100 %)
6 diff
(99.2 %id)
AL711469 human skeletal muscle .vh-u 248 to 870 4 to 625 exact tiling clone,   622/625
(99 %)
6 diff
(99.1 %id)
DC410518 thymus .vi 1 to 597 1 to 597   tiling clone,   597/597
(100 %)
0 diff
(100 %id)
DC322671 brain .vi 92 to 615 1 to 524       524/524
(100 %)
2 diff
(99.7 %id)
DC382478 placenta .vi 120 to 679 1 to 560   tiling clone,   560/560
(100 %)
0 diff
(100 %id)
BG391911 embryonal carcinoma, cell line, testis .vi 121 to 829 1 to 722 R20T L22Y P23L C24V V25L ... tiling clone,   722/848
(85 %)
29 diff
(96.6 %id)
AW405133 lymph .vj 1 to 370 1 to 370 R2G tiling clone,   370/370
(100 %)
5 diff
(98.7 %id)
TI_154142268   .vj 7 to 616 83 to 692       610/612
(99 %)
10 diff
(98.4 %id)
AA618041 lung, lung tumor .vj 215 to 779 561 to 2   tiling clone,   560/568
(98 %)
19 diff
(96.7 %id)
BF965499 Bone, osteosarcoma, cell line .vj 265 to 617 1 to 373       314/374
(83 %)
16 diff
(95.8 %id)
CD640193 pooled .vj 322 to 774 1 to 453   tiling clone,   453/454
(99 %)
3 diff
(99.4 %id)
BX954770   .vk-u 1 to 607 1 to 607 S62N tiling clone,   607/607
(100 %)
2 diff
(99.7 %id)
DA295590 hippocampus .vk-u 33 to 603 2 to 572 S62N capped   571/571
(100 %)
2 diff
(99.7 %id)
DB283840 uterus .vk-u 163 to 686 2 to 525 S62N tiling clone, capped   524/524
(100 %)
2 diff
(99.7 %id)
CK001319 brain/CNS, Bulk tissue from Human Spinal cord .vl 1 to 676 1 to 678 exact tiling clone, AAA Possibly primed on the genome, locally A rich (25/25 A in genome downstream of last aligned base) 678/678
(100 %)
19 diff
(97.2 %id)
DC343345 thalamus .vm 1 to 665 1 to 665 exact tiling clone,   665/665
(100 %)
1 diff
(99.9 %id)
DC407275 thymus .vn 1 to 560 1 to 560 exact tiling clone,   560/560
(100 %)
0 diff
(100 %id)
DC342279 thalamus .vn 60 to 616 1 to 557   tiling clone,   557/557
(100 %)
0 diff
(100 %id)
BX644276   .vo-u 1 to 607 1 to 608 exact tiling clone,   608/608
(100 %)
2 diff
(99.7 %id)
AA456260 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .vp 1 to 219 1 to 219 exact tiling clone, fully sequenced,   219/219
(100 %)
1 diff
(99.6 %id)
TI_149279761   .vp 18 to 606 691 to 104       588/1261
(46 %)
0 diff
(100 %id)
CA310957 Human Lung Epithelial cells, lung .vp 18 to 601 600 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 584/638
(91 %)
0 diff
(100 %id)
TI_149283324   .vp 20 to 601 689 to 107   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 583/690
(84 %)
29 diff
(95.8 %id)
BM969752 lung, Primary Lung Epithelial Cells .vp 45 to 606 574 to 14       561/574
(97 %)
0 diff
(100 %id)
AI333013 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .vp 97 to 601 505 to 1       505/505
(100 %)
1 diff
(99.9 %id)
AI276278 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .vp 110 to 601 492 to 1       492/492
(100 %)
4 diff
(99.2 %id)
AA454647 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .vp 158 to 601 442 to 1   fully sequenced,   442/442
(100 %)
1 diff
(99.8 %id)
BG187920   .vp 183 to 592 21 to 447   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 427/447
(95 %)
56 diff
(87.5 %id)
BG185832   .vp 189 to 602 7 to 420   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 414/420
(98 %)
6 diff
(98.6 %id)
AA885438 pooled .vp 230 to 558 329 to 1       329/329
(100 %)
0 diff
(100 %id)
T91006 liver and spleen .vp 245 to 597 364 to 9       356/405
(87 %)
0 diff
(100 %id)
DC325123 brain .vq 1 to 599 1 to 599 exact tiling clone,   599/599
(100 %)
0 diff
(100 %id)
BG255379 adenocarcinoma, cell line, Prostate .vr 1 to 593 1 to 594 exact tiling clone,   594/692
(85 %)
4 diff
(99.5 %id)
DA494072 brain .vs-u 1 to 582 2 to 584 exact tiling clone, capped   583/583
(100 %)
2 diff
(99.7 %id)
DA176889 amygdala .vs-u 17 to 550 2 to 534 R19V S20P A21Q M22C H23M ... tiling clone, capped   533/533
(100 %)
1 diff
(99.9 %id)
DA202035 brain .vs-u 18 to 590 2 to 573 exact tiling clone, capped   572/572
(100 %)
2 diff
(99.7 %id)
BU160858 melanotic melanoma, cell line, skin .vt 1 to 567 30 to 597 H25R tiling clone,   573/971
(59 %)
13 diff
(98.7 %id)
BQ680113 melanotic melanoma, cell line, skin .vt 1 to 518 3 to 520 H25R     520/987
(52 %)
19 diff
(98.1 %id)
BQ680783 melanotic melanoma, cell line, skin .vt 1 to 526 3 to 529 H25R tiling clone,   529/965
(54 %)
4 diff
(99.6 %id)
BU196845 melanotic melanoma, cell line, skin .vt 20 to 525 18 to 524 R10T R17P H25R A29V     507/1048
(48 %)
20 diff
(98.1 %id)
DC384353   .vu 1 to 552 1 to 553 exact tiling clone,   553/553
(100 %)
1 diff
(99.9 %id)
DA403242 thalamus .vv 1 to 548 2 to 549 exact tiling clone, capped   548/548
(100 %)
1 diff
(99.9 %id)
DC402879 testis .vw 1 to 546 1 to 546 exact tiling clone,   546/546
(100 %)
1 diff
(99.9 %id)
CN311417 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .vx-u 1 to 495 1 to 495 exact tiling clone,   495/495
(100 %)
2 diff
(99.6 %id)
AA096209   Gene BRCA1P1, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
AA248892   Gene BRCA1P1, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
DC323152 brain Gene BRCA1P1, variant not shown         This clone was ignored    
AV684690 hepatocellular carcinoma Gene BRCA1P1, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
AV685828 hepatocellular carcinoma Gene BRCA1P1, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
AI915085 ovary, tumor, 5 pooled (see description) Gene BRCA1P1, variant not shown              
AW104669 ovary, tumor, 5 pooled (see description) Gene BRCA1P1, variant not shown         This clone was ignored    
AW470093 serous papillary carcinoma, high grade, 2pooled tumors, uterus Gene BRCA1P1, variant not shown              
AW339540 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood Gene BRCA1P1, variant not shown              
DB127809 thymus Gene BRCA1P1, variant not shown       capped      
DB344387 thymus Gene BRCA1P1, variant not shown              
DB157374 thymus Gene BRCA1P1, variant not shown       capped      
BQ447474 Knee, Osteoarthritic Cartilage Gene BRCA1P1, variant not shown       AAA This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va-u, .vb, .vc, .vd, .ve, .vf, .vg-u, .vh-u, .vi, .vj, .vk-u, .vl, .vm, .vn, .vo-u, .vp, .vq, .vr, .vs-u, .vt, .vu, .vv, .vw, .vx-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI